ID: ALA226252

Max Phase: Preclinical

Molecular Formula: C13H14Cl2N4O3

Molecular Weight: 345.19

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  Nc1nc(N)c(-c2ccc(Cl)c(Cl)c2)c([C@H](O)[C@H](O)CO)n1

Standard InChI:  InChI=1S/C13H14Cl2N4O3/c14-6-2-1-5(3-7(6)15)9-10(11(22)8(21)4-20)18-13(17)19-12(9)16/h1-3,8,11,20-22H,4H2,(H4,16,17,18,19)/t8-,11-/m1/s1

Standard InChI Key:  SNLSOHKDEZFXSA-LDYMZIIASA-N

Associated Targets(Human)

Dihydrofolate reductase 3072 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Dihydrofolate reductase 79 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Dihydrofolate reductase 68 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 345.19Molecular Weight (Monoisotopic): 344.0443AlogP: 1.00#Rotatable Bonds: 4
Polar Surface Area: 138.51Molecular Species: NEUTRALHBA: 7HBD: 5
#RO5 Violations: 0HBA (Lipinski): 7HBD (Lipinski): 7#RO5 Violations (Lipinski): 1
CX Acidic pKa: 12.69CX Basic pKa: 6.64CX LogP: 0.73CX LogD: 0.66
Aromatic Rings: 2Heavy Atoms: 22QED Weighted: 0.56Np Likeness Score: -0.08

References

1. El-Hamamsy MH, Smith AW, Thompson AS, Threadgill MD..  (2007)  Structure-based design, synthesis and preliminary evaluation of selective inhibitors of dihydrofolate reductase from Mycobacterium tuberculosis.,  15  (13): [PMID:17451962] [10.1016/j.bmc.2007.04.011]

Source